# Paul Rutgeerts

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-rutgeerts/

## Facts

| Field | Value |
| --- | --- |
| Citations | 102,207 |
| Field | Inflammatory Bowel Disease |
| h-index | 139 |
| i10-index | 393 |
| Last Known Institution | KU Leuven |
| OpenAlex ID | https://openalex.org/A5105470583 |
| Works | 879 |

## Researcher papers

- [Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis](https://scholariq.org/papers/vedolizumab-as-induction-and-maintenance-therapy-for-ulcerative-colitis/)
- [Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease](https://scholariq.org/papers/genome-wide-association-defines-more-than-30-distinct-susceptibility-loci-for/)
- [Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease](https://scholariq.org/papers/influence-of-immunogenicity-on-the-long-term-efficacy-of-infliximab-in-crohn-s/)
- [Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease](https://scholariq.org/papers/ustekinumab-as-induction-and-maintenance-therapy-for-crohn-s-disease/)
- [VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death](https://scholariq.org/papers/vegf-is-a-modifier-of-amyotrophic-lateral-sclerosis-in-mice-and-humans-and/)
- [Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study](https://scholariq.org/papers/effects-of-adalimumab-therapy-on-incidence-of-hospitalization-and-surgery-in/)
- [Histamine Receptor H1–Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome](https://scholariq.org/papers/histamine-receptor-h1-mediated-sensitization-of-trpv1-mediates-visceral/)
- [Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection](https://scholariq.org/papers/infliximab-reduces-endoscopic-but-not-clinical-recurrence-of-crohn-s-disease/)
- [Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease](https://scholariq.org/papers/genetic-and-transcriptomic-bases-of-intestinal-epithelial-barrier-dysfunction-in/)
- [A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis](https://scholariq.org/papers/a-panel-to-predict-long-term-outcome-of-infliximab-therapy-for-patients-with/)
- [Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC](https://scholariq.org/papers/specific-members-of-the-predominant-gut-microbiota-predict-pouchitis-following/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Researcher university

- [KU Leuven](https://scholariq.org/institutions/ku-leuven/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.